The medical device testing market, projected to grow from USD 9.3 billion in 2020 to USD 11.8 billion by 2025 at a CAGR of 4.8%, is categorized by services, technology, and region, with the in-vitro diagnostic segment holding the largest share. Key growth is anticipated in the Asia Pacific region, driven by the increasing demand for verification and validation of medical devices. Major players in the market include SGS, Eurofins Scientific, and Bureau Veritas.